Glycobreez F Dpi Capsule
Images are for reference. Actual packaging may vary.
1 units • Other
Glycobreez F Dpi Capsule
Formoterol (12mcg) + Glycopyrrolate (25mcg)
₹379.50
1 units • Other
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Formoterol 12 mcg
+1 more active ingredient
How It Works
Glycopyrrolate blocks muscarinic receptors, leading to decreased secretion of gastric acid and saliva.
Medicine Strength
12 mcg
All Active Ingredients
Formoterol12 mcg
Glycopyrrolate25 mcg
Uses & Benefits
Medical applications
Glycobreez F DPI Capsule is a combination bronchodilator containing Formoterol (12 mcg) and Glycopyrrolate (25 mcg), indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema. Formoterol, a long-acting beta2-adrenergic agonist (LABA), facilitates bronchodilation by relaxing airway smooth muscle, thereby improving airflow and reducing symptoms such as dyspnea and wheezing.
Read full descriptionShow less
Glycopyrrolate, a long-acting muscarinic antagonist (LAMA), complements this effect by inhibiting acetylcholine-mediated bronchoconstriction, leading to sustained airway relaxation. The dry powder inhaler (DPI) formulation ensures targeted delivery to the lungs, enhancing therapeutic efficacy while minimizing systemic exposure. Glycobreez F DPI Capsule is typically administered twice daily and is intended for maintenance therapy rather than acute symptom relief.
It is essential to use this medication under medical supervision, as inappropriate use may lead to adverse effects such as tachycardia, dry mouth, or paradoxical bronchospasm. Patients should be advised to continue their prescribed regimen and not to discontinue therapy abruptly. This combination therapy offers a synergistic approach to improving lung function, reducing exacerbations, and enhancing quality of life in patients with moderate to severe COPD.
Dosage & How to Use
How to use Glycobreez F Powder for Inhalation Use it as advised by your doctor or check the label for directions before use.
Safety Advice
Important precautions
Side effects
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glycobreez F Dpi Capsule.
High Risk
Pregnancy
Glycobreez F Dpi Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
No interaction found/established
Exercise Caution
Liver
No interaction found/established
Regular Checkup
Breastfeeding
Glycobreez F Dpi Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Long-term use of Glycobreez F Dpi Capsule might reduce milk production.
Consult Doctor
Kidney
No interaction found/established
Regular Checkup
Customer Reviews
0 reviews for Glycobreez F Dpi Capsule
